Selected Biomarkers Revealed Potential Skin Toxicity Caused by Certain Copper Compounds
Nevertheless, GLP-1 RAs have gastrointestinal adverse effects such as abdominal pain, constipation, diarrhea, nausea, and vomiting [7]
This session explores what sustainable maintenance looks like in the real world, including lower-dose, longer-duration treatment strategies, and asks what long-term health outcomes, from cardiovascular risk to metabolic function, become possible when treatment is truly sustained
Where once Rybelsus stood alone as the only GLP-1 pill available, patients and clinicians must now navigate three distinct oral products, each with a different molecule, a different approved indication, and a different set of practical requirements